Fonte: International Journal of Pharmaceutics. Unidade: FCF
Assuntos: NANOPARTÍCULAS, LIPÍDEOS
ABNT
OLIVEIRA, Isabela Fernandes de et al. Cutting-edge advances in therapy for the posterior segment of the eye: solid lipid nanoparticles and nanostructured lipid carriers. International Journal of Pharmaceutics, v. 589, p. 1-11 art. 119831, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2020.119831. Acesso em: 16 out. 2024.APA
Oliveira, I. F. de, Barbosa, E. J., Peters, M. C. C., Henostroza, M. A. B., Yukuyama, M. N., Santos Neto, E. dos, et al. (2020). Cutting-edge advances in therapy for the posterior segment of the eye: solid lipid nanoparticles and nanostructured lipid carriers. International Journal of Pharmaceutics, 589, 1-11 art. 119831. doi:10.1016/j.ijpharm.2020.119831NLM
Oliveira IF de, Barbosa EJ, Peters MCC, Henostroza MAB, Yukuyama MN, Santos Neto E dos, Löbenberg R, Bou-Chacra NA. Cutting-edge advances in therapy for the posterior segment of the eye: solid lipid nanoparticles and nanostructured lipid carriers [Internet]. International Journal of Pharmaceutics. 2020 ; 589 1-11 art. 119831.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.ijpharm.2020.119831Vancouver
Oliveira IF de, Barbosa EJ, Peters MCC, Henostroza MAB, Yukuyama MN, Santos Neto E dos, Löbenberg R, Bou-Chacra NA. Cutting-edge advances in therapy for the posterior segment of the eye: solid lipid nanoparticles and nanostructured lipid carriers [Internet]. International Journal of Pharmaceutics. 2020 ; 589 1-11 art. 119831.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.ijpharm.2020.119831